Congenital muscular dystrophies are a group of rare neuromuscular disorders with a wide spectrum of clinical phenotypes. Recent advances in understanding the molecular pathogenesis of congenital muscular dystrophy have enabled better diagnosis. However, medical care for patients with congenital muscular dystrophy remains very diverse. Advances in many areas of medical technology have not been adopted in clinical practice. The International Standard of Care Committee for Congenital Muscular Dystrophy was established to identify current care issues, review literature for evidence-based practice, and achieve consensus on care recommendations in 7 areas: diagnosis, neurology, pulmonology, orthopedics/rehabilitation, gastroenterology/ nutrition/speech/oral care, cardiology, and palliative care. To achieve consensus on the care recommendations, 2 separate online surveys were conducted to poll opinions from experts in the field and from congenital muscular dystrophy families. The final consensus was achieved in a 3-day workshop conducted in Brussels, Belgium, in November 2009. This consensus statement describes the care recommendations from this committee.
Strauss RP, Sharp MC, Lorch SC, Kachalia B.Physicians and the communication of ‘‘bad news’’: parent experiences of being informed of their child’s cleft lip and/or palate. Pediatrics. 1995;96(1, pt 1):82-89.
2.
Sices L., Egbert L., Mercer MBSugar-coaters and straight talkers: communicating about developmental delays in primary care. Pediatrics. 2009;124:e705-713.
3.
Noeker M.Epilepsy-improvement of giving the diagnosis between the demands for standardisation versus individualisation. Seizure. 2004;13:95-98.
4.
Jones KJ, Morgan G., Johnston H., et al. The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: case series and review. J Med Genet. 2001;38:649-657.
5.
Muntoni F., Guicheney P.85th ENMC International Workshop on Congenital Muscular Dystrophy. 6th International CMD Workshop. 1st Workshop of the Myo-Cluster Project GENRE. 27-28th October 2000, Naarden, The Netherlands. Neuromuscul Disord. 2002;12:69-78.
6.
Habeeb YK, Al-Bloushi MA, Al-Jumah ES, De Souza TM, Moosa A.Congenital muscular dystrophy in Arab children. J Child Neurol . 2006;21:400-405.
7.
Mercuri E., Messina S., Bruno C., et al. Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study. Neurology. 2009;72:1802-1809.
8.
Muntoni F., Guicheney P., Voit T.158th ENMC international workshop on congenital muscular dystrophy (Xth international CMD workshop) 8th-10th February 2008 Naarden, The Netherlands. Neuromuscul Disord. 2009;19:229-234.
9.
Bushby K., Muntoni F., Bourke JP107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands. Neuromuscul Disord. 2003;13:166-172.
10.
Ramelli GP, Aloysius A., King C., Davis T., Muntoni F.Gastrostomy placement in paediatric patients with neuromuscular disorders: indications and outcome. Dev Med Child Neurol. 2007;49:367-371.
11.
Philpot J., Bagnall A., King C., Dubowitz V., Muntoni F.Feeding problems in merosin deficient congenital muscular dystrophy. Arch Dis Child. 1999;80:542-547.
12.
Finsterer J. , Stollberger C.Primary myopathies and the heart. Scand Cardiovasc J. 2008;42:9-24.
13.
Miladi N., Bourguignon JP, Hentati F.Cognitive and psychological profile of a Tunisian population of limb girdle muscular dystrophy. Neuromuscul Disord. 1999 ;9:352-354.
14.
Bushby K., Raybould S., O’Donnell S., Steele JGSocial deprivation in Duchenne muscular dystrophy: population based study . BMJ. 2001;323:1035-1036.
15.
Yoshioka M. , Higuchi Y.Long-term prognosis of epilepsies and related seizure disorders in Fukuyama-type congenital muscular dystrophy. J Child Neurol. 2005;20:385-391.
16.
Darke J., Bushby K., Le Couteur A., McConachie H.Survey of behaviour problems in children with neuromuscular diseases. Eur J Paediatr Neurol. 2006;10:129-134.
17.
Vainzof M., Marie SK, Reed UC, et al. Deficiency of merosin (laminin M or alpha 2) in congenital muscular dystrophy associated with cerebral white matter alterations. Neuropediatrics. 1995;26:293-297.
18.
Pini A., Merlini L., Tome FM, Chevallay M., Gobbi G.Merosin-negative congenital muscular dystrophy, occipital epilepsy with periodic spasms and focal cortical dysplasia: report of three Italian cases in two families. Brain Dev. 1996;18:316-322.
19.
Farina L., Morandi L., Milanesi I., et al. Congenital muscular dystrophy with merosin deficiency: MRI findings in five patients. Neuroradiology. 1998;40:807-811.
20.
Tsao CY, Mendell JR, Rusin J., Luquette M.Congenital muscular dystrophy with complete laminin-alpha2-deficiency, cortical dysplasia, and cerebral white-matter changes in children. J Child Neurol. 1998;13:253-256.
21.
Philpot J., Cowan F., Pennock J., et al. Merosin-deficient congenital muscular dystrophy: the spectrum of brain involvement on magnetic resonance imaging. Neuromuscul Disord. 1999;9:81-85.
Vigliano P. , Dassi P., Di Blasi C., Mora M., Jarre L.LAMA2 stopcodon mutation: merosin-deficient congenital muscular dystrophy with occipital polymicrogyria, epilepsy and psychomotor regression. Eur J Paediatr Neurol. 2009;13:72-76.
24.
Fukuyama Y. , Osawa M., Suzuki H.Congenital progressive muscular dystrophy of the Fukuyama type-clinical, genetic and pathological considerations. Brain Dev. 1981;3:1-29.
25.
Santavuori P., Somer H., Sainio K., et al. Muscle-eye-brain disease (MEB). Brain Dev. 1989;11:147-153.
26.
Godfrey C., Clement E., Mein R., et al. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. Brain. 2007;130(pt 10):2725-2735.
27.
Godfrey C., Escolar D., Brockington M., et al. Fukutin gene mutations in steroid-responsive limb girdle muscular dystrophy. Ann Neurol. 2006;60:603-610.
28.
Raitta C., Lamminen M., Santavuori P., Leisti J.Ophthalmological findings in a new syndrome with muscle, eye and brain involvement . Acta Ophthalmol (Copenh). 1978;56:465-472.
29.
Yoshioka M. , Higuchi Y., Fujii T., Aiba H., Toda T.Seizure-genotype relationship in Fukuyama-type congenital muscular dystrophy. Brain Dev. 2008;30:59-67.
30.
Lisi MT, Cohn RDCongenital muscular dystrophies: new aspects of an expanding group of disorders . Biochim Biophys Acta. 2007;1772:159-172.
31.
Lampe AK, Bushby KMCollagen VI related muscle disorders. J Med Genet. 2005;42:673-685.
32.
Merlini L., Bernardi P.Therapy of collagen VI-related myopathies (Bethlem and Ullrich). Neurotherapeutics. 2008;5:613-618.
33.
Nadeau A., Kinali M., Main M., et al. Natural history of Ullrich congenital muscular dystrophy. Neurology. 2009;73:25-31.
34.
Schachter H. , Vajsar J., Zhang W.The role of defective glycosylation in congenital muscular dystrophy. Glycoconj J. 2004;20:291-300.
35.
Mejat A., Decostre V., Li J., et al. Lamin A/C-mediated neuromuscular junction defects in Emery-Dreifuss muscular dystrophy. J Cell Biol. 2009;184:31-44.
36.
Parnaik VK, Manju K.Laminopathies: multiple disorders arising from defects in nuclear architecture . J Biosci. 2006;31:405-421.
Wallgren-Pettersson C., Bushby K., Mellies U., Simonds A.117th ENMC workshop: ventilatory support in congenital neuromuscular disorders-congenital myopathies, congenital muscular dystrophies, congenital myotonic dystrophy and SMA (II) 4-6 April 2003, Naarden, The Netherlands. Neuromuscul Disord. 2004; 14:56-69.
39.
Shahrizaila N. , Kinnear WJ, Wills AJRespiratory involvement in inherited primary muscle conditions. J Neurol Neurosurg Psychiatry. 2006;77:1108-1115.
40.
Mellies U., Dohna-Schwake C., Voit T.Respiratory function assessment and intervention in neuromuscular disorders . Curr Opin Neurol. 2005;18:543-547.
41.
Ragette R., Mellies U., Schwake C., Voit T., Teschler H.Patterns and predictors of sleep disordered breathing in primary myopathies . Thorax. 2002;57:724-728.
42.
Gozal D.Pulmonary manifestations of neuromuscular disease with special reference to Duchenne muscular dystrophy and spinal muscular atrophy. Pediatr Pulmonol. 2000;29:141-150.
43.
Kang SW, Bach JRMaximum insufflation capacity: vital capacity and cough flows in neuromuscular disease. Am J Phys Med Rehabil. 2000;79:222-227.
44.
Panitch HBAirway clearance in children with neuromuscular weakness. Curr Opin Pediatr. 2006;18:277-281.
45.
Dohna-Schwake C., Ragette R., Mellies U., Straub V., Teschler H., Voit T.Respiratory function in congenital muscular dystrophy and limb girdle muscular dystrophy 2I. Neurology . 2004;62: 513-514.
46.
Miske LJ, Hickey EM, Kolb SM, Weiner DJ, Panitch HBUse of the mechanical in-exsufflator in pediatric patients with neuromuscular disease and impaired cough. Chest. 2004;125:1406-1412.
47.
Vianello A. , Corrado A., Arcaro G., et al. Mechanical insufflation-exsufflation improves outcomes for neuromuscular disease patients with respiratory tract infections. Am J Phys Med Rehabil. 2005;84:83-88; discussion 89-91.
48.
Dohna-Schwake C., Ragette R., Teschler H., Voit T., Mellies U.IPPB-assisted coughing in neuromuscular disorders . Pediatr Pulmonol. 2006;41:551-557.
49.
Tzeng AC, Bach JRPrevention of pulmonary morbidity for patients with neuromuscular disease . Chest. 2000;118:1390-1396.
50.
Toussaint M. , De Win H., Steens M., Soudon P.Effect of intrapulmonary percussive ventilation on mucus clearance in duchenne muscular dystrophy patients: a preliminary report. Respir Care. 2003;48:940-947.
51.
Birnkrant DJ , Pope JF, Lewarski J., Stegmaier J., Besunder JBPersistent pulmonary consolidation treated with intrapulmonary percussive ventilation: a preliminary report. Pediatr Pulmonol. 1996;21:246-249.
52.
Reardon CC, Christiansen D., Barnett ED, Cabral HJIntrapulmonary percussive ventilation vs incentive spirometry for children with neuromuscular disease. Arch Pediatr Adolesc Med. 2005;159:526-531.
53.
Goldberg, A.Consensus Statement: Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation-a consensus conference report. Chest. 1999;116:521-534.
54.
Katz S., Selvadurai H., Keilty K., Mitchell M., MacLusky I.Outcome of non-invasive positive pressure ventilation in paediatric neuromuscular disease. Arch Dis Child. 2004;89:121-124.
55.
Young HK, Lowe A., Fitzgerald DA, et al. Outcome of noninvasive ventilation in children with neuromuscular disease. Neurology. 2007;68:198-201.
56.
Ward S., Chatwin M., Heather S., Simonds AKRandomised controlled trial of non-invasive ventilation (NIV) for nocturnal hypoventilation in neuromuscular and chest wall disease patients with daytime normocapnia. Thorax. 2005;60:1019-1024.
57.
Vianello A. , Bevilacqua M., Arcaro G., Gallan F., Serra E.Non-invasive ventilatory approach to treatment of acute respiratory failure in neuromuscular disorders: a comparison with endotracheal intubation. Intensive Care Med. 2000;26:384-390.
58.
Servera E., Sancho J., Zafra MJ, Catala A., Vergara P., Marin J.Alternatives to endotracheal intubation for patients with neuromuscular diseases . Am J Phys Med Rehabil. 2005;84:851-857.
59.
Padman R., Lawless ST, Kettrick RGNoninvasive ventilation via bilevel positive airway pressure support in pediatric practice. Crit Care Med. 1998;26:169-173.
60.
Dohna-Schwake C., Podlewski P., Voit T., Mellies U.Non-invasive ventilation reduces respiratory tract infections in children with neuromuscular disorders. Pediatr Pulmonol. 2008;43:67-71.
61.
Stubgen JPRigid spine syndrome: a radiologic and manometric study of the pharynx and esophagus. Dysphagia. 2008;23:110-115.
62.
Hill M., Hughes T., Milford C.Treatment for swallowing difficulties (dysphagia) in chronic muscle disease. Cochrane Database Syst Rev. 2004; (2): CD004303.
63.
Balasubramaniam R., Sollecito TP, Stoopler ETOral health considerations in muscular dystrophies . Spec Care Dentist. 2008;28:243-253.
64.
Morel-Verdebout C., Botteron S., Kiliaridis S.Dentofacial characteristics of growing patients with Duchenne muscular dystrophy: a morphological study. Eur J Orthod. 2007;29:500-507.
65.
Mielnik-Blaszczak M., Malgorzata B.Duchenne muscular dystrophy-a dental healthcare program. Spec Care Dentist. 2007;27:23-25.
66.
Driscoll SW , Skinner J.Musculoskeletal complications of neuromuscular disease in children. Phys Med Rehabil Clin N Am. 2008; 19:163-194; viii.
67.
Mullender M. , Blom N., De Kleuver M., et al. A Dutch guideline for the treatment of scoliosis in neuromuscular disorders. Scoliosis. 2008;3:14.
68.
Fujak A., Ingenhorst A., Heuser K., Forst R., Forst J.Treatment of scoliosis in intermediate spinal muscular atrophy (SMA type II) in childhood. Ortop Traumatol Rehabil. 2005 ;7:175-179.
69.
Zeller R.Neuromuscular scoliosis: follow-up of treatment and therapeutic principles . Orthopade. 2000;29:518-523.
70.
Richardson M., Frank AOElectric powered wheelchairs for those with muscular dystrophy: problems of posture, pain and deformity. Disabil Rehabil Assist Technol. 2009;4:181-188.
71.
Engel JM, Kartin D., Carter GT, Jensen MP, Jaffe KMPain in youths with neuromuscular disease. Am J Hosp Palliat Care. 2009;26:405-412.
72.
Jones R., Khan R., Hughes S., Dubowitz V.Congenital muscular dystrophy: the importance of early diagnosis and orthopaedic management in the long-term prognosis. J Bone Joint Surg Br . 1979;61:13-17.
73.
Morillon S., Thumerelle C., Cuisset JM, Santos C., Matran R., Deschildre A.Effect of thoracic bracing on lung function in children with neuromuscular disease. Ann Readapt Med Phys. 2007; 50:645-650.
74.
Duval-Beaupere G., Poiffaut A., Bouvier CL, Garibal JC, Assicot J.Molded plexidur corrective corsets in the treatment of paralytic scolioses: evaluation after 7 years usage. Acta Orthop Belg. 1975;41:652-659.
75.
Quijano-Roy S. , Mbieleu B., Bonnemann CG, et al. De novo LMNA mutations cause a new form of congenital muscular dystrophy. Ann Neurol. 2008;64:177-186.
76.
Mercuri E., Brown SC, Nihoyannopoulos P., et al. Extreme variability of skeletal and cardiac muscle involvement in patients with mutations in exon 11 of the lamin A/C gene. Muscle Nerve. 2005; 31:602-609.
77.
Makri S., Clarke NF, Richard P., et al. Germinal mosaicism for LMNA mimics autosomal recessive congenital muscular dystrophy. Neuromuscul Disord. 2009 ;19:26-28.
78.
Kefi M., Amouri R., Chabrak S., Mechmeche R., Hentati F.Variable cardiac involvement in Tunisian siblings harboring FKRP gene mutations . Neuropediatrics. 2008;39:113-115.
79.
Louhichi N. , Triki C., Quijano-Roy S., et al. New FKRP mutations causing congenital muscular dystrophy associated with mental retardation and central nervous system abnormalities: identification of a founder mutation in Tunisian families . Neurogenetics. 2004;5:27-34.
80.
Hayashi YK, Ogawa M., Tagawa K., et al. Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy. Neurology. 2001;57:115-121.
81.
Nakanishi T. , Sakauchi M., Kaneda Y., et al. Cardiac involvement in Fukuyama-type congenital muscular dystrophy. Pediatrics. 2006;117:e1187-1192.
82.
Gilhuis HJ, ten Donkelaar HJ, Tanke RB, et al. Nonmuscular involvement in merosin-negative congenital muscular dystrophy. Pediatr Neurol. 2002;26:30-36.
83.
Spyrou N., Philpot J., Foale R., Camici PG, Muntoni F.Evidence of left ventricular dysfunction in children with merosin-deficient congenital muscular dystrophy. Am Heart J. 1998;136:474-476.
84.
Quijano-Roy S., Galan L., Ferreiro A., et al. Severe progressive form of congenital muscular dystrophy with calf pseudohypertrophy, macroglossia and respiratory insufficiency. Neuromuscul Disord. 2002;12:466-475.
85.
Merlini L., Martoni E., Grumati P., et al. Autosomal recessive myosclerosis myopathy is a collagen VI disorder . Neurology. 2008;71: 1245-1253.
86.
Pace RA, Peat RA, Baker NL, et al. Collagen VI glycine mutations: perturbed assembly and a spectrum of clinical severity. Ann Neurol. 2008;64:294-303.
87.
Moghadaszadeh B., Petit N., Jaillard C., et al. Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome . Nat Genet. 2001;29:17-18.
88.
Flanigan KM , Kerr L., Bromberg MB, et al. Congenital muscular dystrophy with rigid spine syndrome: a clinical, pathological, radiological, and genetic study. Ann Neurol. 2000;47: 152-161.
89.
Mercuri E., Talim B., Moghadaszadeh B., et al. Clinical and imaging findings in six cases of congenital muscular dystrophy with rigid spine syndrome linked to chromosome 1p (RSMD1). Neuromuscul Disord. 2002;12:631-638.
90.
Meune C., Van Berlo JH, Anselme F., Bonne G., Pinto YM, Duboc D.Primary prevention of sudden death in patients with lamin A/C gene mutations . N Engl J Med. 2006;354:209-210.
91.
Berul CI, Van Hare GF, Kertesz NJ, et al. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol. 2008;51:1685-1691.
92.
McClain BC, Kain ZNPediatric palliative care: a novel approach to children with sickle cell disease . Pediatrics. 2007;119:612-614.
93.
Tiffreau V. , Viet G., Thevenon A.Pain and neuromuscular disease: the results of a survey. Am J Phys Med Rehabil. 2006;85:756-766.
94.
Mah JK, Thannhauser JE, Kolski H., Dewey D.Parental stress and quality of life in children with neuromuscular disease . Pediatr Neurol. 2008;39:102-107.
95.
Ahlstrom G. , Sjoden POCoping with illness-related problems and quality of life in adult individuals with muscular dystrophy. J Psychosom Res. 1996;41:365-376.
